Please use this identifier to cite or link to this item: http://ahro.austin.org.au/austinjspui/handle/1/10443
Title: Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes.
Authors: Srivastava, Piyush M;Calafiore, Paul;Macisaac, Richard J;Patel, Sheila K;Thomas, Merlin C;Jerums, George;Burrell, Louise M
Affiliation: Department of Medicine, University of Melbourne, Austin Health, Heidelberg, Victoria 3081, Australia.
Issue Date: 1-Feb-2008
Citation: Clinical Science (london, England : 1979); 114(4): 313-20
Abstract: The aim of the present study was to determine the prevalence and predictors of an abnormal echocardiogram in patients with Type 2 diabetes. Cardiac function and structure were rigorously assessed by comprehensive transthoracic echocardiographic techniques in 229 patients with Type 2 diabetes. Cardiovascular risk factors and diabetic complications were assessed, and predictors of an abnormal echocardiogram were identified using multivariate logistic regression analysis. An abnormal echocardiogram was present in 166 patients (72%). LVH (left ventricular hypertrophy) occurred in 116 patients (51%), and cardiac dysfunction was found in 146 patients (64%), of whom 109 had diastolic dysfunction alone and 37 had systolic+/-diastolic dysfunction. Independent predictors of an abnormal echocardiogram were obesity, age, the number of antihypertensive drugs used (all P<0.001) and creatinine clearance (P<0.05). The risk of an abnormal echocardiogram increased by 9% for each year over 50 years of age {OR (odds ratio), 1.09 [95% CI (confidence interval), 1.04-1.15]}, 3-fold if obesity was present [BMI (body mass index) >30; OR, 4.2 (95% CI, 1.9-9.0)] and by 80% for each antihypertensive agent used [OR, 1.8 (95% CI, 1.3-2.4) per agent]. In conclusion, an abnormal cardiac echocardiogram is common in patients with Type 2 diabetes. Importantly, although cardiac abnormalities can be predicted by traditional risk factors, such as age, obesity and renal function, the absence of micro- or macro-vascular complications does not predict a normal echocardiogram. We suggest that an echocardiogram identifies those with Type 2 diabetes at increased cardiovascular risk due to occult LVH and diastolic dysfunction, and this information may lead to more aggressive management of known risk factors in the clinic.
Internal ID Number: 17916064
URI: http://ahro.austin.org.au/austinjspui/handle/1/10443
DOI: 10.1042/CS20070261
URL: http://www.ncbi.nlm.nih.gov/pubmed/17916064
Type: Journal Article
Subjects: Aging.physiology
Analysis of Variance
Antihypertensive Agents.therapeutic use
Cardiomegaly.epidemiology.physiopathology.ultrasonography
Creatine.metabolism
Cross-Sectional Studies
Diabetes Complications.epidemiology.physiopathology.ultrasonography
Diabetes Mellitus, Type 2.physiopathology.ultrasonography
Echocardiography, Doppler
Electrocardiography
Female
Humans
Kidney.metabolism
Logistic Models
Male
Metabolic Clearance Rate
Middle Aged
Myocardium.pathology
Obesity.complications.physiopathology.ultrasonography
Prevalence
Appears in Collections:Journal articles

Files in This Item:
There are no files associated with this item.


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.